Related references
Note: Only part of the references are listed.The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer
S. Albisinni et al.
PROGRES EN UROLOGIE (2019)
Postoperative Serum C-Reactive Protein Level Predicts Long-term Outcomes in Stage I Gastric Cancer
Kazuhiro Migita et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma
Kota Arima et al.
AMERICAN JOURNAL OF SURGERY (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Allan Ramos-Esquivel
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer
David G. Watt et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
Jianhong Peng et al.
CHINESE JOURNAL OF CANCER (2017)
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study
Takeharu Yamanaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer
Zhen-Yu Zou et al.
ONCOLOGY LETTERS (2016)
Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy
Gui-Nan Lin et al.
CHINESE JOURNAL OF CANCER (2016)
Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
Y. Chang et al.
BRITISH JOURNAL OF CANCER (2015)
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer
Valeria Josa et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
M. Stotz et al.
BRITISH JOURNAL OF CANCER (2014)
Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin
Greg Yothers et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
Daniel G. Haller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Serum albumin as a significant prognostic factor for patients with gastric carcinoma
Luis F. Onate-Ocana et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Inhibition of albumin synthesis in chronic diseases - Molecular mechanisms
M Chojkier
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss
DC McMillan et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)
Share Paper
